British biotech Oxford Nanopore prepares for $3 billion London IPO

Oxford Nanopore said it has started preparing for a potential initial public offering, which could value the U.K.-based biotech revolutionizing DNA sequencing at more than £2 billion ($3 billion).
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.